Comparing MicroRNA Profilings of Purified HER-2-Negative and HER-2-Positive Cells Validates miR-362-5p/Sema3A as Characteristic Molecular Change in Triple-Negative Breast Cancers

<div>MicroRNA microarray analysis of HER-2-negative and HER-2-positive breast cancer cells. (a) Unsupervised hierarchical clustering analysis of the 21 microRNAs differentially expressed between the HER-2-negative and HER-2-positive breast cancer cells. Higher intensities of red indicate higher expression levels, while lower intensities of green indicate lower expression levels. (b) Fold change of 16 differential expression microRNAs which was upregulated in TNBC cells.</div>

Disease Markers

fig2

Figure 2

Figure 2: Comparing MicroRNA Profilings of Purified HER-2-Negative and HER-2-Positive Cells Validates miR-362-5p/Sema3A as Characteristic Molecular Change in Triple-Negative Breast Cancers 

Figure 2 | Comparing MicroRNA Profilings of Purified HER-2-Negative and HER-2-Positive Cells Validates miR-362-5p/Sema3A as Characteristic Molecular Change in Triple-Negative Breast Cancers 